Evidence map›Paper›PMID 21848623›Full record

ArticleVeterinary and comparative oncology2011

Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells.

S-H Hong, T Osborne, L Ren, J Briggs, C Mazcko, S S Burkett, C Khanna

Open access · greenAbstract read
In one paragraph

Article in Veterinary and comparative oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Canine and murine models of osteosarcoma.Veterinary pathology · 2022
    Review
  6. Review
  7. Molecular Mechanisms of Canine Osteosarcoma Metastasis.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Comparative oncology: what dogs and other species can teach us about humans with cancer.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Review
  13. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

S-H HongTumor and Metastasis Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. hongsu@mail.nih.gov
T Osborne
L Ren
J Briggs
C Mazcko
S S Burkett
C Khanna
National Institutes of Health · USCenter for Cancer Research · USNational Cancer Institute · US

Funding

Tumor and Metastasis BiologyZIABC010566 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HELMAN, LEE J. · 2009 to 2017
$4.6M
Tumor and Metastasis TherapyZIABC011024 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KHANNA, CHAND · 2009 to 2013
$3.2M
Tumor and Metastasis BiologyZ01BC010566 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KHANNA, CHAND · 2005 to 2008
$1.8M
Comparative Oncology ProgramZ01BC010569 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KHANNA, CHAND · 2005 to 2008
$743k
Intramural NIH HHS Z01 BC010566Intramural NIH HHS Z01 BC010569
6 · The paper itself

Abstract

The development of metastasis is the most significant cause of death for both canine and human patients with osteosarcoma (OS). Ezrin has been associated with tumour progression and metastasis in human, canine and murine OS. Ezrin activation is dynamically regulated by protein kinase C (PKC) during metastatic progression in human and murine OS. To include the dog in the development of therapeutics that target ezrin biology, we characterized four new canine OS cell lines and confirmed the relationship between PKC and ezrin in these cells. Three of four cell lines formed tumours in mice that were histologically consistent with OS. All cell lines were markedly aneuploid and expressed ezrin and PKC. Finally, both ezrin phosphorylation and cell migration were inhibited using a PKC inhibitor. These data suggest that an association between PKC-mediated activation of ezrin and the metastatic phenotype in canine OS cells.

Indexed as

AnimalsBone NeoplasmsCell Line, TumorCell MovementCytoskeletal ProteinsDog DiseasesDogsEzrinFemaleMembrane ProteinsMiceMice, SCIDMicrofilament ProteinsNeoplasm MetastasisOsteosarcomaPhosphorylationCytoskeletal ProteinsEzrinMembrane ProteinsMicrofilament ProteinsmoesinProtein Kinase Cradixin

Identifiers

PMID21848623
PMCPMC7394284
OpenAlexW2106445033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.